Roche Acquires Genentech – Combined Synergy to Create a Global Leader in Healthcare - PDF by GlobalData

VIEWS: 122 PAGES: 11

More Info
									Roche Acquires Genentech –
Combined Synergy to Create a
Global Leader in Healthcare
                                                                              Reference Code: GDME0672VPT

                                                                              Publication Date: DEC 2008




Medical Equipment Viewpoint                                                    GDME0672VPT / Published DEC 2008
© GlobalData. This brief is a licensed product and is not to be photocopied                                 Page 1
Table of Contents

1            Table of Contents

1      Table of Contents ........................................................................................................2

1.1        List of Figures..................................................................................................................................................... 3


2      GlobalData Viewpoint ..................................................................................................4

2.1        Summary .............................................................................................................................................................. 4


3 Roche Acquires Genentech - Combined Synergy to Create a Global Leader in
Healthcare ..........................................................................................................................5

3.1        Summary .............................................................................................................................................................. 5

3.2        IVD Market Overview......................................................................................................................................... 5

3.3        History .................................................................................................................................................................. 6

3.4        Rationale of the Deal...............................................................................................
								
To top